Detect
Drug Pattern
in test-compounds and select the
most useful ones,
before screening them all.
Case study: Analysing compound databases
Buying compounds from external suppliers increases the size of in-house database and can yield to further hits in HTS campaigns. But only a small amount of substances have suitable features to become a drug. MolScores-Drugs revealed that up to 80% of the compounds offered are not useful for pharmaceutical customers. Here are three examples of our observations:
Supplier database with 33.277 compounds
Supplier database with 245.912 compounds
Supplier database with 304.642 compounds
The database has 33.277 compounds. As many as 72% had a MolScore-Drugs result of lower than 0,5 and are therefore unlikely to suit the customer’s needs. A further 18% can also be excluded. The decision threshold is set by the customer, who can incorporate the results via SDF-file import into his own software.
56%
16%
10%
18%
MolScore-Drugs
0 0,5 1
66%
12%
9%
13%
Number of molecules per row
MolScore-Drugs
0 0,5 1
33.277 compounds
245.912 compounds
Analysis of supplier database (33.277 compounds)
The database has 245.912 compounds. 78% had a MolScore-Drugs result lower than 0,5 and are therefore unlikely to suit the customer’s needs.
Number of molecules per row
63%
11%
14%
12%
Number of molecules per row
MolScore-Drugs
0 0,5 1
304.642 compounds
The database has 304.642 compounds. The supplier advertised the recent addition of drug-like molecules by using rules of thumb like “Rule of 5” for selecting compounds. This can be seen in the graphic by an increase in the region 0,8-1,0. However, in our test as many as 74% had a MolScore-Drugs result lower than 0,5 and are consequently unlikely to suit the customer’s needs.
© Copyright 2004-2021 PharmaInformatic Boomgaarden. All rights reserved. Site map Contact Terms of Use Imprint |